Lyophilized Microbiota Capsule for Gut Restoration
Solution Overview
Problem
Current treatments for digestive tract diseases and conditions lack effective alternative compositions and methods, particularly in addressing drug-resistant organisms and restoring normal intestinal microbiota.
Innovation Solution
The development of an oral microbiota restoration therapy (MRT) composition involving the collection, purification, stabilization, and encapsulation of stool samples to create a treatment form that can restore healthy gut microbiota, using methods such as lyophilization and encapsulation in capsules, and packaging for oral administration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If stool samples are collected and processed for microbiota restoration therapy, then effective treatment for digestive tract diseases and drug-resistant organisms is achieved, but the complexity of the manufacturing process increases
Solution Approach 1:
The manufacturing process is divided into distinct sequential steps: collection, purification, concentration, stabilization, and formulation. Each step processes the stool sample independently with specific objectives, making the overall complex process manageable and controllable through modular operations.
Solution Approach 2:
Multiple intermediate forms are created during processing: purified sample, concentrated sample, stabilized sample, and formulation mixture. These intermediates serve as transition states that facilitate the transformation from raw stool material to final therapeutic composition, allowing quality control at each stage.
2Manufacturing precision
If purification and concentration steps are applied to stool samples, then the quality and efficacy of the MRT composition is improved, but the manufacturing time and processing duration increase
Solution Approach 1:
Purification and concentration operations are performed on the stool sample before stabilization and formulation. By preparing the sample in advance with removed contaminants and adjusted concentration, the subsequent steps can proceed more efficiently without requiring reprocessing or correction.
Solution Approach 2:
The physical and chemical parameters of the stool sample are systematically adjusted during processing: particle size reduction through purification, concentration through removal of supernatant, and stabilization through controlled conditions. These parameter changes optimize the sample for therapeutic use while streamlining subsequent manufacturing steps.
3Duration of action of stationary object
If stabilization and formulation steps are implemented, then the shelf life and storage stability of the MRT composition is improved, but the manufacturing complexity and operational difficulty increase
Solution Approach 1:
The stabilization step involves changing parameters such as moisture content, pH, and atmospheric conditions to create a stable formulation that resists degradation. The formulation step adjusts composition parameters including excipient ratios and physical form, resulting in a product with extended shelf life and predictable storage characteristics.
Solution Approach 2:
The process uses disposable single-use components and containers for sample processing and formulation. This eliminates the need for complex cleaning and sterilization procedures between batches, reducing operational difficulty while maintaining product stability through controlled, contained processing environments.
4Ease of operation
If encapsulation is applied to the MRT composition, then the ease of administration and patient compliance is improved, but the manufacturing process complexity increases
Solution Approach 1:
The MRT composition is enclosed in capsule shells that provide a flexible, protective container suitable for oral administration. The encapsulation process fills these pre-formed shells with the formulated composition, creating a ready-to-administer dosage form that simplifies patient use while adding a standardized manufacturing step.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The MRT composition effectively treats conditions like Clostridium difficile infections and other drug-resistant organisms by normalizing intestinal microbiota, providing a viable alternative for treating digestive tract issues and infections.
Implementation Method 1
lyophilizing the purified intermediate to form a plurality lyophilized pellets
Implementation Method 2
lyophilizing the purified intermediate
Implementation Method 3
centrifuging the filtrate to arrive at the purified intermediate
Data Source
Figure 1
Figure 2
Figure 3
AI summary
An oral pharmaceutical composition comprises a capsule and a lyophilized material disposed within the capsule, the lyophilized material comprising fecal microbiota, polyethylene glycol, trehalose, sucrose, and glycerin.